Operating CF
$1.36B
Capex
-$269M
Free Cash Flow
$1.09B
FCF Margin
+80.2%
Cash flow waterfall for Edwards Lifesciences (EW) — TTM through Q1 2026
Free cash flow: $1.09B
Note: Other Investing is large — driven mainly by purchases or sales of investments.
Cash flow breakdown for Edwards Lifesciences (EW) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $1.36B | $1.36B |
| Capital Expenditure | -$269M | $1.09B |
| Free Cash Flow | $1.09B | $1.09B |
| Acquisitions | -$35.1M | $1.05B |
| Other Investing | -$587M | $468M |
| Share Buybacks | -$411M | $56.7M |
| Other Financing & FX | -$758M | -$701M |
| Net Cash Decrease | -$701M | -$701M |
- Operating Cash Flow$1.36B
- Capital Expenditure-$269M
- Free Cash Flow$1.09B
- Acquisitions-$35.1M
- Other Investing-$587M
- Share Buybacks-$411M
- Other Financing & FX-$758M
- Net Cash Decrease-$701M
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
How this company returns cash to shareholders — buybacks, dividends, and stock splits.